
    
      Secondary objectives for this protocol are to 1) assess the kinetics of lymphohematopoietic
      reconstitution and 2) describe the short and long-term (up to 5 years post- transplant)
      toxicity of haploidentical stem cell transplantation, including GVHD, in children with
      refractory hematological malignancies.
    
  